Found 14 matching trials
Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients PHASE2 This study assesses the potential of using a TGFβ receptor inhibitor for th...
Show More Location
Weill Medical College of Cornell University
Learn More & Join Trial
Effect of Food on the Pharmacokinetics of TEW-7197 in Healthy Subjects PHASE1 Participants in this study will receive 200 milligram (mg) TEW-7197 taken a...
Show More Location
Inje University Busan Paik Hospital
Learn More & Join Trial
Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma PHASE1 MP-VAC-209 is a Phase I/II, open label, single arm, multi-center study to a...
Show More Location
UH Rainbow Babies & Children's Hospital
Learn More & Join Trial
Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma PHASE1 The purpose of this study is to see if the study drug, called Vactosertib, ...
Show More Location
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma. PHASE1 To determine recommended phase 2 dose and to evaluate the safety of vactose...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer PHASE1 This is an open-label, multicenter study to assess the safety, tolerability...
Show More Location
National Cancer Center
Learn More & Join Trial
Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel PHASE1 * Inclusion
1. Subjects who are males or females ≥ 19 years of age
2. ...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS PHASE1 This is a prospective, open-label, multicenter, phase 1/2 study of TEW-7197...
Show More Learn More & Join Trial
TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer PHASE1 This is an open-label, single arm study evaluating the safety and tolerabil...
Show More Location
Hallym University Medical Center
Learn More & Join Trial
As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkers PHASE2 This clinical trial is to evaluate the efficacy and safety of subjects with...
Show More Location
Multiple Locations
Learn More & Join Trial